rawfin.tv
Aldeyra Therapeutics Faces Securities Fraud Lawsuit Deadline
RegulationstocksAI Generated

Aldeyra Therapeutics Faces Securities Fraud Lawsuit Deadline

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

The Rosen Law Firm reminds investors of the deadline to lead a securities fraud lawsuit against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX). Investors who purchased ALDX securities between specific dates and incurred losses exceeding $100,000 may be eligible.

Aldeyra TherapeuticsSecurities FraudLawsuitBiotech Stocks

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks